Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang Feng

Showing results (381-390 of 399) with videos related to

Pageof 40
Sort By:
Chinese Medical Journal|July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in ChinaXi Li, Yan Gao, Jing Li, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2016
The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study designXue Du, Yi Pi, Rachel P Dreyer, et al.
Molecular Cancer|August 18, 2021
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Chinese Medical Journal|December 30, 2015
China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study DesignJing Li, Rachel P Dreyer, Xi Li, et al.
Molecular Therapy. Methods & Clinical Development|January 8, 2024
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamstersHung-Chun Liao, Kuan-Yin Shen, Chung-Hsiang Yang, et al.
Acta Pharmacologica Sinica|July 4, 2018
Identification of compound D2923 as a novel anti-tumor agent targeting CSF1RYing-Qiang Liu, Ya-Nan Wang, Xiao-Yun Lu, et al.
Molecular Cancer|August 19, 2023
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Molecular Cancer|May 15, 2020
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Medcomm|April 27, 2026
Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR InhibitorMengzhen Lai, Jiaying Chen, Ye Qin, et al.
Cancer Science|December 2, 2021
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoYingqiang Liu, Mengzhen Lai, Shan Li, et al.
Pageof 40

Showing results (381-390 of 399) with videos related to

Sort By:
Pageof 40
Chinese Medical Journal|July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in ChinaXi Li, Yan Gao, Jing Li, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2016
The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study designXue Du, Yi Pi, Rachel P Dreyer, et al.
Molecular Cancer|August 18, 2021
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Chinese Medical Journal|December 30, 2015
China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study DesignJing Li, Rachel P Dreyer, Xi Li, et al.
Molecular Therapy. Methods & Clinical Development|January 8, 2024
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamstersHung-Chun Liao, Kuan-Yin Shen, Chung-Hsiang Yang, et al.
Acta Pharmacologica Sinica|July 4, 2018
Identification of compound D2923 as a novel anti-tumor agent targeting CSF1RYing-Qiang Liu, Ya-Nan Wang, Xiao-Yun Lu, et al.
Molecular Cancer|August 19, 2023
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Molecular Cancer|May 15, 2020
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang, Rong Qu, Shingpan Chan, et al.
Medcomm|April 27, 2026
Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR InhibitorMengzhen Lai, Jiaying Chen, Ye Qin, et al.
Cancer Science|December 2, 2021
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoYingqiang Liu, Mengzhen Lai, Shan Li, et al.
Pageof 40